Lauren Sciences

Lauren Sciences LLC, founded in 2008 and based in New York, is a private biotech company tackling the fundamental challenge of delivering therapeutics across the blood-brain barrier. Its proprietary V-Smart® Platform enables the targeted CNS delivery of biologics, nucleic acids, and small molecules that otherwise cannot reach the brain. The company is in a pre-clinical/pre-revenue stage, developing an internal pipeline for major neurological diseases while also pursuing collaborations with pharmaceutical partners to deploy its platform with their proprietary agents.

V-Smart® Platform: a non-invasive, triple-targeted nanomedicine platform designed to transport a wide range of therapeutic agents (nucleic acids, antibodies, biologics, small molecules) across the blood-brain barrier.

The BBB drug delivery field is crowded with diverse approaches, including focused ultrasound, receptor-mediated transcytosis, and other nanoparticle technologies from both biotech startups and large pharma. Lauren Sciences must differentiate its V-Smart® Platform through robust pre-clinical data and successful translation into clinical efficacy.